The Haystack Project
  • Home
  • About Us Participants Partners Board and Staff
  • Legislative Priorities
  • PROTECT Rare
  • New Rare Disease Approval Pathway HEART Act
  • Speaker Series Payer Engagement Health Equity Rare Cancer
  • Inflation Reduction Act Medicare Section 340b Medicaid FDA ICER
  • Patient Stories
  • Join
  • Take Action
The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Staff
  • Legislative Priorities/
  • PROTECT Rare/
  • FDA/
    • New Rare Disease Approval Pathway
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
Newspapers.png
The Haystack Project

Haystack News

The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Staff
  • Legislative Priorities/
  • PROTECT Rare/
  • FDA/
    • New Rare Disease Approval Pathway
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
March 13, 2023

Haystack's Comments in response to CMS' Medicare Part B Inflation Rebate Guidance

March 13, 2023/ Cara Tenenbaum

See our comments here

March 13, 2023/ Cara Tenenbaum/
Comments
CMS, Medicare

Cara Tenenbaum

  • Haystack's comments in response to ...
  • Haystack Releases POV Report on ...

About Us

The Issues

Resources

News & Updates

© 2020 Haystack Project. All Rights Reserved. 

 

Contact Us

Please consider making a tax-deductible donation to support the Haystack Project today.

The Haystack Project is a 501(c)3 nonprofit that brings together patients organizations representing patients suffering from or caring for patients with extremely rare diseases. Our mission is to educate policymakers and other stakeholders about the need for policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.